{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T06:04:23Z","timestamp":1775714663792,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T00:00:00Z","timestamp":1484006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373608"],"award-info":[{"award-number":["81373608"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00520-016-3560-0","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T02:22:33Z","timestamp":1484014953000},"page":"1651-1659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Anamorelin for cancer anorexia-cachexia syndrome: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"25","author":[{"given":"Yu","family":"Bai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanhua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xizhong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"key":"3560_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.critrevonc.2015.12.008","volume":"99","author":"R Tarricone","year":"2016","unstructured":"Tarricone R, Ricca G, Nyanzi-Wakholi B, Medina-Lara A (2016) Impact of cancer anorexia-cachexia syndrome on health-related quality of life and resource utilisation: a systematic review. Crit Rev Oncol Hematol 99:49\u201362","journal-title":"Crit Rev Oncol Hematol"},{"key":"3560_CR2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3322\/canjclin.52.2.72","volume":"52","author":"A Inui","year":"2002","unstructured":"Inui A (2002) Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52:72\u201391","journal-title":"CA Cancer J Clin"},{"key":"3560_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13539-010-0002-6","volume":"1","author":"S Haehling von","year":"2010","unstructured":"von Haehling S, Anker SD (2010) Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 1:1\u20135","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3560_CR4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.ctrv.2015.09.002","volume":"41","author":"A Esposito","year":"2015","unstructured":"Esposito A, Criscitiello C, Gelao L, Pravettoni G, Locatelli M, Minchella I, Di Leo M, Liuzzi R, Milani A, Massaro M, Curigliano G (2015) Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist. Cancer Treat Rev 41:793\u2013797","journal-title":"Cancer Treat Rev"},{"key":"3560_CR5","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jpainsymman.2006.10.015","volume":"34","author":"SC Teunissen","year":"2007","unstructured":"Teunissen SC, Wesker W, Kruitwagen C, de Haes HC, Voest EE, de Graeff A (2007) Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 34:94\u2013104","journal-title":"J Pain Symptom Manag"},{"key":"3560_CR6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12:489\u2013495","journal-title":"Lancet Oncol"},{"key":"3560_CR7","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6601781","volume":"90","author":"PJ Ross","year":"2004","unstructured":"Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O'Brien ME (2004) Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers. Br J Cancer 90:1905\u20131911","journal-title":"Br J Cancer"},{"key":"3560_CR8","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/annonc\/mdu085","volume":"25","author":"M Aapro","year":"2014","unstructured":"Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, Hopkinson J, Jacquelin-Ravel N, Jatoi A, Kaasa S, Strasser F (2014) Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol 25:1492\u20131499","journal-title":"Ann Oncol"},{"key":"3560_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/01635581.2015.976318","volume":"67","author":"P Mondello","year":"2015","unstructured":"Mondello P, Mian M, Aloisi C, Fama F, Mondello S, Pitini V (2015) Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options. Nutr Cancer 67:12\u201326","journal-title":"Nutr Cancer"},{"key":"3560_CR10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1615\/CritRevOncog.v17.i3.80","volume":"17","author":"C Madeddu","year":"2012","unstructured":"Madeddu C, Maccio A, Mantovani G (2012) Multitargeted treatment of cancer cachexia. Crit Rev Oncog 17:305\u2013314","journal-title":"Crit Rev Oncog"},{"key":"3560_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/J354v21n04_14","volume":"21","author":"A Shih","year":"2007","unstructured":"Shih A, Jackson KN (2007) Role of corticosteroids in palliative care. J Pain Palliat Care Pharmacother 21:69\u201376","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"3560_CR12","doi-asserted-by":"crossref","first-page":"22382","DOI":"10.1074\/jbc.M100938200","volume":"276","author":"JA Keifer","year":"2001","unstructured":"Keifer JA, Guttridge DC, Ashburner BP, Baldwin AJ (2001) Inhibition of NF-\u03baB activity by thalidomide through suppression of I\u03baB kinase activity. J Biol Chem 276:22382\u201322387","journal-title":"J Biol Chem"},{"key":"3560_CR13","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1749-6632.2002.tb04674.x","volume":"973","author":"SH Jin","year":"2002","unstructured":"Jin SH, Kim TI, Han DS, Shin SK, Kim WH (2002) Thalidomide suppresses the interleukin 1beta-induced NFkappaB signaling pathway in colon cancer cells. Ann N Y Acad Sci 973:414\u2013418","journal-title":"Ann N Y Acad Sci"},{"key":"3560_CR14","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","volume":"13","author":"K Lundholm","year":"2007","unstructured":"Lundholm K, Korner U, Gunnebo L, Sixt-Ammilon P, Fouladiun M, Daneryd P, Bosaeus I (2007) Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res 13:2699\u20132706","journal-title":"Clin Cancer Res"},{"key":"3560_CR15","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1210\/jcem.85.12.7167","volume":"85","author":"K Takaya","year":"2000","unstructured":"Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K (2000) Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908\u20134911","journal-title":"J Clin Endocrinol Metab"},{"key":"3560_CR16","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1164\/rccm.200604-511OC","volume":"176","author":"R Wu","year":"2007","unstructured":"Wu R, Dong W, Zhou M, Zhang F, Marini CP, Ravikumar TS, Wang P (2007) Ghrelin attenuates sepsis-induced acute lung injury and mortality in rats. Am J Respir Crit Care Med 176:805\u2013813","journal-title":"Am J Respir Crit Care Med"},{"key":"3560_CR17","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2006.01.041","volume":"130","author":"E Gonzalez-Rey","year":"2006","unstructured":"Gonzalez-Rey E, Chorny A, Delgado M (2006) Therapeutic action of ghrelin in a mouse model of colitis. Gastroenterology 130:1707\u20131720","journal-title":"Gastroenterology"},{"key":"3560_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2169\/internalmedicine.45.1402","volume":"45","author":"N Nagaya","year":"2006","unstructured":"Nagaya N, Kojima M, Kangawa K (2006) Ghrelin, a novel growth hormone-releasing peptide, in the treatment of cardiopulmonary-associated cachexia. Intern Med 45:127\u2013134","journal-title":"Intern Med"},{"key":"3560_CR19","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1210\/en.2007-0016","volume":"148","author":"MD DeBoer","year":"2007","unstructured":"DeBoer MD, Zhu XX, Levasseur P, Meguid MM, Suzuki S, Inui A, Taylor JE, Halem HA, Dong JZ, Datta R, Culler MD, Marks DL (2007) Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. Endocrinology 148:3004\u20133012","journal-title":"Endocrinology"},{"key":"3560_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/B978-0-12-410473-0.00003-9","volume":"92","author":"B Guillory","year":"2013","unstructured":"Guillory B, Splenser A, Garcia J (2013) The role of ghrelin in anorexia-cachexia syndromes. Vitam Horm 92:61\u2013106","journal-title":"Vitam Horm"},{"key":"3560_CR21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.peptides.2011.01.021","volume":"32","author":"N Morozumi","year":"2011","unstructured":"Morozumi N, Hanada T, Habara H, Yamaki A, Furuya M, Nakatsuka T, Inomata N, Minamitake Y, Ohsuye K, Kangawa K (2011) The role of C-terminal part of ghrelin in pharmacokinetic profile and biological activity in rats. Peptides 32:1001\u20131007","journal-title":"Peptides"},{"key":"3560_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/cpdd.175","volume":"4","author":"PT Leese","year":"2015","unstructured":"Leese PT, Trang JM, Blum RA, de Groot E (2015) An open-label clinical trial of the effects of age and gender on the pharmacodynamics, pharmacokinetics and safety of the ghrelin receptor agonist anamorelin. Clin Pharmacol Drug Dev 4:112\u2013120","journal-title":"Clin Pharmacol Drug Dev"},{"key":"3560_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ghir.2008.12.003","volume":"19","author":"JM Garcia","year":"2009","unstructured":"Garcia JM, Polvino WJ (2009) Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers. Growth Hormon IGF Res 19:267\u2013273","journal-title":"Growth Hormon IGF Res"},{"key":"3560_CR24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00520-012-1500-1","volume":"21","author":"JM Garcia","year":"2013","unstructured":"Garcia JM, Friend J, Allen S (2013) Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer 21:129\u2013137","journal-title":"Support Care Cancer"},{"key":"3560_CR25","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S1470-2045(14)71154-4","volume":"16","author":"JM Garcia","year":"2015","unstructured":"Garcia JM, Boccia RV, Graham CD, Yan Y, Duus EM, Allen S, Friend J (2015) Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. The Lancet Oncology 16:108\u2013116","journal-title":"The Lancet Oncology"},{"key":"3560_CR26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","volume":"17","author":"JS Temel","year":"2016","unstructured":"Temel JS, Abernethy AP, Currow DC, Friend J, Duus EM, Yan Y, Fearon KC (2016) Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol 17:519\u2013531","journal-title":"Lancet Oncol"},{"key":"3560_CR27","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","volume":"24","author":"K Takayama","year":"2016","unstructured":"Takayama K, Katakami N, Yokoyama T, Atagi S, Yoshimori K, Kagamu H, Saito H, Takiguchi Y, Aoe K, Koyama A, Komura N, Eguchi K (2016) Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial. Support Care Cancer 24:3495\u20133505","journal-title":"Support Care Cancer"},{"key":"3560_CR28","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5","volume":"88","author":"VT Chang","year":"2000","unstructured":"Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton symptom assessment scale. Cancer 88:2164\u20132171","journal-title":"Cancer"},{"key":"3560_CR29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ije\/dyl224","volume":"36","author":"CR Gale","year":"2007","unstructured":"Gale CR, Martyn CN, Cooper C, Sayer AA (2007) Grip strength, body composition, and mortality. Int J Epidemiol 36:228\u2013235","journal-title":"Int J Epidemiol"},{"key":"3560_CR30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13539-014-0159-5","volume":"5","author":"C Pietra","year":"2014","unstructured":"Pietra C, Takeda Y, Tazawa-Ogata N, Minami M, Yuanfeng X, Duus EM, Northrup R (2014) Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle 5:329\u2013337","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3560_CR31","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00520-013-1800-0","volume":"21","author":"R Northrup","year":"2013","unstructured":"Northrup R, Kuroda K, Duus EM, Barnes SR, Cheatham L, Wiley T, Pietra C (2013) Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model. Support Care Cancer 21:2409\u20132415","journal-title":"Support Care Cancer"},{"key":"3560_CR32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1517\/14656566.2015.1041500","volume":"16","author":"H Zhang","year":"2015","unstructured":"Zhang H, Garcia JM (2015) Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC. Expert Opin Pharmacother 16:1245\u20131253","journal-title":"Expert Opin Pharmacother"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3560-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-016-3560-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-016-3560-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:46:35Z","timestamp":1498362395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-016-3560-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["3560"],"URL":"https:\/\/doi.org\/10.1007\/s00520-016-3560-0","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]}}}